中文

力诺药包 Revenue Breakdown

Period 2026-03-31 ・ Reported 2026-04-23
ItemAmountY/Y
Revenue¥0.32B+16.0%
Gross profit¥0.09B
Operating income¥0.05B
Net income¥0.04B+1.2%
Gross margin26.9%Net margin 12.8%
Revenue Q/Q+22.9%

Revenue Segments

The filing did not disclose a revenue breakdown for this period.

Costs & Expenses

ItemAmount% of revenue
Cost of revenue¥0.23B73.1%
R&D¥0.01B2.3%
SG&A¥0.02B7.0%
Tax & other¥0.01B2.9%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

奥尼电子善水科技菲菱科思泰祥股份家联科技北路智控唯科科技工大科雅喜悦智行迈赫股份大族数控诚达药业

Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies